Cardiac tissue engineering for the treatment of hypoplastic left heart syndrome (HLHS).
Cardiac tissue engineering for the treatment of hypoplastic left heart syndrome (HLHS).
复制标题
DOI:
10.21037/tp-23-127
复制
发表时间:
2023-08-30
影响因子:
2
通讯作者:
中科院分区:
文献类型:
--
作者:
Hypoplastic left heart syndrome (HLHS) is a deadly congenital heart disease that arises when the left ventricle and outflow tract fail to develop appropriately, inhibiting the adequate perfusion of the rest of the body. Historically, this disease has been treated via a series of surgeries that allows the heart to use a single ventricle. These surgeries are often a palliative measure, and heart transplantation is the only definitive therapy that exists for this condition. It has been hypothesized that stem cell-based regenerative therapies could have a role in promoting cardiac tissue regeneration in HLHS patients who are undergoing palliative surgery. Several clinical trials have demonstrated that introducing pluripotent cells into the heart is safe, feasible, and capable of improving right ventricular ejection fraction (RVEF). However, while these approaches show great promise, there is still room for development. There is a substantial body of pre-clinical work that is focused on generating increasingly large and complex pieces of cardiac tissue in the form of cardiac patches, with the idea that these could be used to rebuild and strengthen the heart in a robust and long-lasting manner. In total, stem cell-based therapies have much to offer when it comes to improving the treatment of HLHS.
登录
查看更多内容
影响因子:
2.6
作者:
Best KE;Miller N;Draper E;Tucker D;Luyt K;Rankin J
通讯作者:
Rankin J
影响因子:
4.7
作者:
Matsuzaki Y;Wiet MG;Boe BA;Shinoka T
通讯作者:
Shinoka T
影响因子:
3.6
作者:
Mei X;Cheng K
通讯作者:
Cheng K
影响因子:
6
作者:
Peral, Susana Cantero;Burkhart, Harold M.;Nelson, Timothy J.
通讯作者:
Nelson, Timothy J.
影响因子:
1.3
作者:
Javed, Rabia;Cetta, Frank;Qureshi, Muhammad Yasir
通讯作者:
Qureshi, Muhammad Yasir